Figures
- Figure 1.
Relationship between the mean 6-min walk distance at baseline and the rate of fatal events during follow-up. Reproduced from [24] with permission from the publisher.
- Figure 2.
Kaplan–Meier survival estimates in patients with pulmonary arterial hypertension stratified by median 6-min walk distance (6MWD) after 4 months of bosentan monotherapy. Reproduced from [21] with permission from the publisher.
- Figure 3.
Relationship between change in 6-min walk distance (Δ6MWD) and a) composite outcome, b) all-cause mortality, c) hospitalisation for pulmonary arterial hypertension and/or lung or heart–lung transplantation, and d) initiation of pulmonary arterial hypertension rescue therapy. Reproduced from [29] with permission from the publisher.
- Figure 4.
Effect of macitentan on morbidity and mortality. #: risk reduction 30%, hazard ratio 0.70, p=0.01. ¶: risk reduction 45%, hazard ratio 0.55, p<0.001. Reproduced from [31] with permission from the publisher.
Additional Files
Disclosures
Files in this Data Supplement:
